Australian Psychiatry Review

In October Australian Psychiatry Review features a focus section on cerebral organoids, an exciting new technique for exploring neurodevelopmental processes using cells taken from adults. The literature review includes Gin Malhi’s critique of the poorly defined and variably implemented diagnosis of schizoaffective disorder and evidence by Lopez and colleagues suggesting recent claims of the severe harms of prescription of antipsychotic medications for behavioural disturbances in dementia in nursing homes may be overstated. Koesters and colleagues show that agomelatine is ineffective for depression when negative unpublished data are considered, while Harrow and Jobe argue that the benefits of long-term antipsychotic therapy for schizophrenia have not been convincingly demonstrated. And now, let’s consider research in Australian psychiatric journals.